222 related articles for article (PubMed ID: 10051534)
1. Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme.
D'Amours MR; Granovsky AE; Artemyev NO; Cote RH
Mol Pharmacol; 1999 Mar; 55(3):508-14. PubMed ID: 10051534
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.
Zhang X; Feng Q; Cote RH
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3060-6. PubMed ID: 16123402
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5.
Cote RH
Int J Impot Res; 2004 Jun; 16 Suppl 1():S28-33. PubMed ID: 15224133
[TBL] [Abstract][Full Text] [Related]
4. Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021.
Miyahara M; Ito M; Itoh H; Shiraishi T; Isaka N; Konishi T; Nakano T
Eur J Pharmacol; 1995 Sep; 284(1-2):25-33. PubMed ID: 8549633
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021.
Ito M; Nishikawa M; Fujioka M; Miyahara M; Isaka N; Shiku H; Nakano T
Cell Signal; 1996 Dec; 8(8):575-81. PubMed ID: 9115850
[TBL] [Abstract][Full Text] [Related]
6. A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.
Saeki T; Adachi H; Takase Y; Yoshitake S; Souda S; Saito I
J Pharmacol Exp Ther; 1995 Feb; 272(2):825-31. PubMed ID: 7853200
[TBL] [Abstract][Full Text] [Related]
7. Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5.
Granovsky AE; Artemyev NO
J Biol Chem; 2001 Jun; 276(24):21698-703. PubMed ID: 11285263
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
Gillespie PG; Beavo JA
Mol Pharmacol; 1989 Nov; 36(5):773-81. PubMed ID: 2555675
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs.
Chiu PJ; Vemulapalli S; Chintala M; Kurowski S; Tetzloff GG; Brown AD; Sybertz EJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):463-9. PubMed ID: 9109362
[TBL] [Abstract][Full Text] [Related]
10. The gamma subunit of the rod photoreceptor cGMP phosphodiesterase can modulate the proteolysis of two cGMP binding cGMP-specific phosphodiesterases (PDE6 and PDE5) by caspase-3.
Frame M; Wan KF; Tate R; Vandenabeele P; Pyne NJ
Cell Signal; 2001 Oct; 13(10):735-41. PubMed ID: 11602184
[TBL] [Abstract][Full Text] [Related]
11. Identification of the gamma subunit-interacting residues on photoreceptor cGMP phosphodiesterase, PDE6alpha '.
Granovsky AE; Artemyev NO
J Biol Chem; 2000 Dec; 275(52):41258-62. PubMed ID: 11024033
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor.
Vemulapalli S; Watkins RW; Chintala M; Davis H; Ahn HS; Fawzi A; Tulshian D; Chiu P; Chatterjee M; Lin CC; Sybertz EJ
J Cardiovasc Pharmacol; 1996 Dec; 28(6):862-9. PubMed ID: 8961086
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.
Cohen AH; Hanson K; Morris K; Fouty B; McMurty IF; Clarke W; Rodman DM
J Clin Invest; 1996 Jan; 97(1):172-9. PubMed ID: 8550830
[TBL] [Abstract][Full Text] [Related]
14. Probing domain functions of chimeric PDE6alpha'/PDE5 cGMP-phosphodiesterase.
Granovsky AE; Natochin M; McEntaffer RL; Haik TL; Francis SH; Corbin JD; Artemyev NO
J Biol Chem; 1998 Sep; 273(38):24485-90. PubMed ID: 9733741
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibitor sensitivity between human recombinant and native photoreceptor cGMP-phosphodiesterases (PDE6s).
Zhang J; Kuvelkar R; Wu P; Egan RW; Billah MM; Wang P
Biochem Pharmacol; 2004 Sep; 68(5):867-73. PubMed ID: 15294449
[TBL] [Abstract][Full Text] [Related]
16. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
Ohnishi M; Oka M; Muramatsu M; Sato K; Kira S; Fukuchi Y
J Cardiovasc Pharmacol; 1999 Apr; 33(4):619-24. PubMed ID: 10218733
[TBL] [Abstract][Full Text] [Related]
17. Probing the catalytic sites and activation mechanism of photoreceptor phosphodiesterase using radiolabeled phosphodiesterase inhibitors.
Liu YT; Matte SL; Corbin JD; Francis SH; Cote RH
J Biol Chem; 2009 Nov; 284(46):31541-7. PubMed ID: 19758990
[TBL] [Abstract][Full Text] [Related]
18. cGMP binding to noncatalytic sites on mammalian rod photoreceptor phosphodiesterase is regulated by binding of its gamma and delta subunits.
Mou H; Grazio HJ; Cook TA; Beavo JA; Cote RH
J Biol Chem; 1999 Jun; 274(26):18813-20. PubMed ID: 10373499
[TBL] [Abstract][Full Text] [Related]
19. A conformational switch in the inhibitory gamma-subunit of PDE6 upon enzyme activation by transducin.
Granovsky AE; Artemyev NO
Biochemistry; 2001 Nov; 40(44):13209-15. PubMed ID: 11683629
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of transducin activation of frog rod photoreceptor phosphodiesterase. Allosteric interactiona between the inhibitory gamma subunit and the noncatalytic cGMP-binding sites.
Norton AW; D'Amours MR; Grazio HJ; Hebert TL; Cote RH
J Biol Chem; 2000 Dec; 275(49):38611-9. PubMed ID: 10993884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
